Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 139.60 INR
Change Today +3.10 / 2.27%
Volume 19.0K
RPGL On Other Exchanges
Symbol
Exchange
Natl India
As of 1:13 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

rpg life sciences ltd (RPGL) Snapshot

Open
139.40
Previous Close
136.50
Day High
141.80
Day Low
131.75
52 Week High
04/8/15 - 175.70
52 Week Low
05/7/14 - 64.60
Market Cap
2.3B
Average Volume 10 Days
66.9K
EPS TTM
32.29
Shares Outstanding
16.5M
EX-Date
09/11/14
P/E TM
4.3x
Dividend
1.20
Dividend Yield
1.43%
Current Stock Chart for RPG LIFE SCIENCES LTD (RPGL)

Related News

No related news articles were found.

rpg life sciences ltd (RPGL) Related Businessweek News

No Related Businessweek News Found

rpg life sciences ltd (RPGL) Details

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic dosage forms, and synthetic and fermentation active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic/anti-depressant, anti-thrombotic, anti-anginal, anti-helmentic, anti-convulsant, anti-spasmodic, and anti-cancer. It also provides generics primarily in the area of immunosuppressant therapy; finished dosage formulations for various therapies, such as gastro-intestinal, pain management, cardio-vascular, and nephrology primarily under the Lomotil, Lomofen, Naprosyn, Azoran, Aldactone, and Serenace brand names; and biotechnology products in the areas of oncology. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is based in Mumbai, India.

1,200 Employees
Last Reported Date: 09/1/14
Founded in 1968

rpg life sciences ltd (RPGL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

rpg life sciences ltd (RPGL) Key Developments

RPG Life Sciences Ltd Announces Board Changes

RPG Life Sciences Ltd. announced that the Board of Directors of the company at its meeting held on January 23, 2015, has appointed Mr. Sachin Nandgaonkar as a Non-executive Director in a casual vacancy caused by resignation of Mr. C. Vinayarghavan.

RPG Life Sciences Limited Announces Unaudited Standalone Financial Results for the Third Quarter and Nine Months Ended December 31, 2014

RPG Life Sciences Limited announced unaudited standalone financial results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales of INR 564.8 million against INR 547.9 million a year ago. Profit from operations before other income and finance costs and exceptional items was INR 30.7 million against loss from operations before other income and finance costs and exceptional items of INR 55.9 million a year ago. Profit from ordinary activities before tax was INR 26.7 million against loss from ordinary activities before tax of INR 54.4 million a year ago. Net profit for the period was INR 25.3 million or INR 1.53 per diluted share against net loss for the period of INR 30.2 million or INR 1.83 per diluted loss per share a year ago. For the nine months, the company reported net sales of INR 1,718.9 million against INR 1,782.4 million a year ago. Loss from operations before other income and finance costs and exceptional items was INR 28.5 million against profit from operations before other income and finance costs and exceptional items of INR 14 million a year ago. Profit from ordinary activities before tax was INR 37.0 million against profit from ordinary activities before tax of INR 656.3 million a year ago. Net loss for the period was INR 37.0 million or INR 2.24 per diluted share against net profit for the period of INR 539.1 million or INR 32.60 per diluted share a year ago.

RPG Life Sciences Ltd Appoints Mr. C. T. Renganathan as Additional Director and Managing Director

RPG Life Sciences Ltd. has informed that the Board has appointed Mr. C. T. Renganathan as an Additional Director and as the Managing Director for a term of 3 years with effect from January 02, 2015 subject To Approve the shareholders of the company and such other regulatory approvals as may be necessary.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RPGL:IN 139.60 INR +3.10

RPGL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RPGL.
View Industry Companies
 

Industry Analysis

RPGL

Industry Average

Valuation RPGL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.0x
Price/Book 1.9x
Price/Cash Flow 34.6x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RPG LIFE SCIENCES LTD, please visit www.rpglifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.